Evidence map›Paper›PMID 38301651›Full record

ArticleImmunity2024

Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response.

Nikolai P Jaschke, Dorit Breining, Maura Hofmann, Sophie Pählig, Ulrike Baschant, Reinhard Oertel, Sofia Traikov, Tatyana Grinenko, Francesco Saettini, Andrea Biondi and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Lactate and lactylation in intervertebral disc degeneration.Frontiers in molecular biosciences · 2025
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 5 countries.

Nikolai P JaschkeDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; Department of Internal Medicine (Rheumatology, Allergy & Immunology) and Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. Electronic address: nikolai.jaschke@yale.edu.
Dorit BreiningDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Maura HofmannDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Sophie PähligDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Ulrike BaschantDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Reinhard OertelInstitute of Clinical Pharmacology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Sofia TraikovMax-Planck Institute of Molecular Cell Biology, Dresden, Germany.
Tatyana GrinenkoInstitute of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Jiao Tong University School of Medicine, Shanghai, China.
Francesco SaettiniTettamanti Research Center, University of Milano-Bicocca, University of Milano Bicocca, Monza, Italy.
Andrea BiondiCentro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; Pediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy; Dipartimento di Medicina e Chirurgia, Università degli Studi Milano-Bicocca, Monza, Italy.
Myrto StylianouBiotechnology Center (Biotec) Technische Universität Dresden, Dresden, Germany.
Henrik BringmannBiotechnology Center (Biotec) Technische Universität Dresden, Dresden, Germany.
Cuiling ZhangDepartment of Internal Medicine (Rheumatology, Allergy & Immunology) and Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Tomomi M YoshidaDepartment of Internal Medicine (Rheumatology, Allergy & Immunology) and Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Heike WeidnerDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Wolfram C PollerCardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Filip K SwirskiCardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Andy GöbelDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Lorenz C HofbauerDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Martina RaunerDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Christoph ScheiermannDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Biomedical Center (BMC), Institute for Cardiovascular Physiology and Pathophysiology, Walter Brendel-Center for Experimental Medicine (WBex), Faculty of Medicine, Ludwig-Maximilians-Universität Munich, Planegg-Martinsried, Germany.
Andrew WangDepartment of Internal Medicine (Rheumatology, Allergy & Immunology) and Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
Tilman D RachnerDivision of Endocrinology, Department of Medicine III, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
TU Dresden · DEYale University · USIcahn School of Medicine at Mount Sinai · USUniversity of Milano-Bicocca · ITLudwig-Maximilians-Universität München · DEMax Planck Institute of Molecular Cell Biology and Genetics · DE

Funding

Dissecting How Xenobiotics Act as Adjuvants for Oral Allergic SensitizationR01AI162645 · NIAID · YALE UNIVERSITY · PI Andrew Wang · 2021 to 2026
$3.6M
The Role of the Adrb3/IL6 Axis in the Impact of Psychosocial Stress on Lupus PathogenesisR01AR080104 · NIAMS · YALE UNIVERSITY · PI Andrew Wang · 2022 to 2026
$2.2M
NIAID NIH HHS R01 AI162645NIAMS NIH HHS R01 AR080104
6 · The paper itself

Abstract

Mutations of the CBP/p300 histone acetyltransferase (HAT) domain can be linked to leukemic transformation in humans, suggestive of a checkpoint of leukocyte compartment sizes. Here, we examined the impact of reversible inhibition of this domain by the small-molecule A485. We found that A485 triggered acute and transient mobilization of leukocytes from the bone marrow into the blood. Leukocyte mobilization by A485 was equally potent as, but mechanistically distinct from, granulocyte colony-stimulating factor (G-CSF), which allowed for additive neutrophil mobilization when both compounds were combined. These effects were maintained in models of leukopenia and conferred augmented host defenses. Mechanistically, activation of the hypothalamus-pituitary-adrenal gland (HPA) axis by A485 relayed shifts in leukocyte distribution through corticotropin-releasing hormone receptor 1 (CRHR1) and adrenocorticotropic hormone (ACTH), but independently of glucocorticoids. Our findings identify a strategy for rapid expansion of the blood leukocyte compartment via a neuroendocrine loop, with implications for the treatment of human pathologies.

Indexed as

Bone MarrowHistone AcetyltransferasesHistonesHumansHypothalamo-Hypophyseal SystemNeutrophilsHistone AcetyltransferasesHistonesbone marrow failureBone marrow mobilizationCBP/p300G-CSFglucocorticoidsHAT domainHPA axisneutropenianeutrophilsRubinstein-Taybi syndrome

Identifiers

PMID38301651
PMCPMC10923082
OpenAlexW4391406450

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.